The Expression of Endothelin-1 and Endothelin-Converting Enzyme-1 (ECE-1) are Independently Regulated in Bovine Aortic Endothelial Cells
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 33 (4) , 671-677
- https://doi.org/10.1097/00005344-199904000-00023
Abstract
The endopeptidase called endothelin-converting enzyme-1 (ECE-1) is thought to play a physiological role in endothelin-1 (ET-1) biosynthesis. For human ECE-1, differential splicing of messenger RNA (mRNA) results in the synthesis of three isoforms, termed ECE-1a, ECE-1b, and ECE-1c. The isoform(s) responsible for the hydrolysis of the biosynthetic intermediate big ET-1 in endothelial cells have yet to be assigned. To investigate whether the expression of mRNAs for preproET-1 and ECE-1 are regulated in parallel, a variety of conditions were used to compare levels of ET-1 synthesis by bovine aortic endothelial cells (BAECs) with levels of mRNA for preproET-1, ECE-1a, ECE-1c, and the combined ECE-1 isoforms (ECE-1a/b/c). Stimulation of BAECs with tumor necrosis factor-α or transforming growth factor-β increased ET-1 synthesis, and treatment of BAECs with 2-chloroadenosine or staurosporine caused concentration-dependent reductions in ET-1 synthesis. Estimates of mRNA levels by reverse transcription-polymerase chain reaction (RT-PCR) with linear cycling conditions showed changes in preproET-1 expression to correlate well with ET-1 secretion. In contrast, RT-PCR analysis of ECE-1 expression by using primer pairs to measure ECE-1a, ECE-1c, or all the ECE-1 isoforms simultaneously showed no correlation between their mRNA levels and those of preproET-1. This indicates that under the conditions investigated, expression of ECE-1 is not coordinated with ET-1 synthesis in BAECs.Keywords
This publication has 42 references indexed in Scilit:
- Endothelin-Converting EnzymeHypertension, 1998
- Identification and characterization of two isoforms of an endothelin‐converting enzyme‐1FEBS Letters, 1995
- Cloning and Sequencing of a Human Endothelin Converting Enzyme in Renal Adenocarcinoma (ACHN) Cells Producing Endothelin-2Biochemical and Biophysical Research Communications, 1995
- Cloning and Functional Expression of Human Endothelin-Converting Enzyme cDNABiochemical and Biophysical Research Communications, 1995
- A Simple Method for Isolating Human Endothelin Converting Enzyme Free from Contamination by Neutral Endopeptidase 24.11Biochemical and Biophysical Research Communications, 1995
- Molecular characterization of human and bovine endothelin converting enzyme (ECE‐1)FEBS Letters, 1994
- Pharmacological Profile of a Non-peptidic Dual Inhibitor of Neutral Endopeptidase 24.11 and Endothelin-Converting EnzymeBiochemical and Biophysical Research Communications, 1994
- Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymeBiochemical and Biophysical Research Communications, 1990
- Endothelium-Removal Decreases Relaxations of Canine Coronary Arteries Caused by β-Adrenergic Agonists and AdenosineJournal of Cardiovascular Pharmacology, 1985